Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GM-CSF Adjuvant Therapy in High-Risk Melanoma
NCT00350597Phase 2Completed
- Start
- Sep 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim in Malignant Melanoma (MM). Started Sep 2004; status: completed.
02
Drugs
sargramostim
03
Conditions
Malignant Melanoma (MM)
Beyond the preview
Go deeper on NCT00350597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00350597.